Corcept Therapeutics (CORT) Change in Taxes (2021 - 2025)

Corcept Therapeutics has disclosed Change in Taxes across 5 years of filings, most recently posting $1.0 million for Q4 2025.

• Change in Taxes for Q4 2025 came in at $1.0 million, down 15.6% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.1 million (down 71.09% YoY), and the FY2025 annual result was $1.1 million, down 71.09% from the prior year.
• Change in Taxes came in at $1.0 million for Q4 2025 at Corcept Therapeutics, up from -$1.5 million in the prior quarter.
• In the past five years, Change in Taxes ranged from a high of $2.5 million in Q2 2022 to a low of -$1.5 million in Q3 2025.
• The 5-year median for Change in Taxes is $579500.0 (2021), against an average of $738900.0.
• Across the five-year window, Change in Taxes surged 56950.0% in 2022 and plunged 269.78% in 2025, its largest moves.
• Corcept Therapeutics' Change in Taxes stood at -$4000.0 in 2021, then soared by 56950.0% to $2.3 million in 2022, then tumbled by 107.17% to -$163000.0 in 2023, then surged by 858.9% to $1.2 million in 2024, then fell by 15.6% to $1.0 million in 2025.
• The last three Change in Taxes figures came in at $1.0 million (Q4 2025), -$1.5 million (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.